Examkin

Soru

Zorluk: ZorClinical Preventive Services and Screening

An established 66-year-old patient visits the ambulatory clinic for a comprehensive health evaluation. She mentions that she generally feels well, though she experienced a brief episode of minimal brownish vaginal spotting three weeks ago, which she attributed to age-related vaginal dryness. Her medical history includes type 2 diabetes mellitus, hypertension, and severe plaque psoriasis currently managed with infliximab. She has smoked a pack of cigarettes daily since age 25. Review of her electronic health record shows a normal screening colonoscopy four years ago, and consecutive negative cervical cytology with high-risk HPV co-testing at ages 58 and 63. She requests to have her annual flu shot today, specifically asking for "the nasal spray version" she saw in an advertisement. Which of the following combinations of diagnostic and preventive interventions is the most appropriate management plan for this patient?

  1. Perform an endometrial biopsy, order a low-dose chest computed tomography, and administer the inactivated intramuscular influenza vaccineCevap
  2. B
    Reassure the patient regarding the vaginal spotting, order a low-dose chest computed tomography, and administer the inactivated intramuscular influenza vaccine
  3. C
    Perform an endometrial biopsy, order a low-dose chest computed tomography, and administer the live-attenuated intranasal influenza vaccine
  4. D
    Perform cervical cytology with HPV co-testing, order a low-dose chest computed tomography, and administer the inactivated intramuscular influenza vaccine
  5. E
    Perform an endometrial biopsy, order a screening colonoscopy, and administer the inactivated intramuscular influenza vaccine

Cevap

The most appropriate management plan is to perform an endometrial biopsy, order a low-dose chest computed tomography, and administer the inactivated intramuscular influenza vaccine.
The correct answer accurately synthesizes the patient's clinical and preventive needs. First, any postmenopausal bleeding—even scant spotting attributed by the patient to dryness—must be evaluated with an endometrial biopsy or transvaginal ultrasound to rule out endometrial carcinoma. Second, the patient is 66 years old with a 41 pack-year smoking history and continues to smoke, which meets the USPSTF criteria for annual lung cancer screening with a low-dose chest computed tomography. Third, because she is on infliximab (a TNF-alpha inhibitor) for severe psoriasis, she is immunosuppressed. Live-attenuated vaccines, such as the intranasal influenza vaccine, are contraindicated; therefore, she must receive the inactivated intramuscular influenza vaccine. Finally, she does not require cervical cancer screening (she is >65 with adequate negative prior testing) or colonoscopy (normal screening 4 years ago, next due in 6 years).

Adım Adım Çözüm

1
Evaluate the vaginal spotting.
The patient has postmenopausal bleeding, which requires an endometrial biopsy.
Any vaginal bleeding in a postmenopausal woman must be evaluated to rule out endometrial cancer, regardless of the amount or the patient's assumptions about vaginal atrophy.
2
Determine the appropriate cancer screenings based on her age and history.
She needs a low-dose chest CT (LDCT) but does not need cervical or colon cancer screening.
She has a 41 pack-year smoking history and is a current smoker (age 66), meeting USPSTF criteria for annual LDCT. Her colonoscopy 4 years ago was normal, so she is not due. She meets exit criteria for cervical cancer screening (age >65 years with adequate negative prior screens).
3
Determine the appropriate influenza vaccine formulation.
She must receive the inactivated intramuscular influenza vaccine.
She is taking infliximab, an immunosuppressive biologic agent. Live-attenuated vaccines (like the intranasal flu vaccine) are strictly contraindicated in immunosuppressed patients.

Anahtar Kavram

Comprehensive preventive care requires integrating diagnostic workups for new symptoms (e.g., postmenopausal bleeding) with age- and risk-appropriate screenings (e.g., LDCT for smokers), while tailoring immunizations to the patient's immune status.
Bu soruyu puanla

Konular

Clinical Preventive Services and Screening

Bu konudan daha fazla soru